Skip to main content
Nutrients logoLink to Nutrients
. 2021 Apr 24;13(5):1445. doi: 10.3390/nu13051445

Polyphenols Rich Diets and Risk of Type 2 Diabetes

Andrea Da Porto 1,*, Alessandro Cavarape 1, GianLuca Colussi 1, Viviana Casarsa 1, Cristiana Catena 1, Leonardo A Sechi 1
Editors: Benno Zimmermann1, Sabine Ellinger1
PMCID: PMC8146556  PMID: 33923263

Abstract

Type 2 diabetes is an increasing health concern worldwide. Both genetic and environmental risk factors as improper dietary habits or physical inactivity are known to be crucial in the pathogenesis of type 2 diabetes. Polyphenols are a group of plant-derived compounds with anti-inflammatory and antioxidant properties that are associated with a low prevalence of metabolic conditions characterized by insulin resistance, including obesity, diabetes, and hypertension. Moreover, there is now full awareness that foods that are rich in phytochemicals and polyphenols could play an important role in preserving human cardiovascular health and substantial clinical evidence indicates that regular dietary consumption of such foods affects favorably carbohydrate metabolism. This review briefly summarizes the evidence relating dietary patterns rich in polyphenols with glucose metabolism and highlights the potential benefits of these compounds in the prevention of type 2 diabetes.

Keywords: polyphenols, diet, dietary patterns, diabetes

1. Introduction

The chemical structure of phenols is characterized by an aromatic ring with at least one hydroxyl group and can vary [1] from simple molecules to complex polymers with high molecular weight. Although there is some disagreement concerning their categorization, a classification that has been commonly used in the medical literature subdivides phenols in two main groups: Flavonoids and non-flavonoid polyphenols [2,3]. The flavonoid group comprises flavanones, flavones, dihydroflavonols, flavonols, flavan-3-ols, isoflavones, anthocyanidins, proanthocyanidins, and chalcones, all compounds with a C6-C3-C6 structure. Non-flavonoid polyphenols are classified on the basis of their carbon skeleton into different subgroups: Simple phenols, benzoic acids, hydrolysable tannins, acetophenones, phenylacetic acids, cinnamic acids, lignans, coumarins, benzophenones, xanthones, stilbenes, and secoiridoids [4].

Hundreds of different polyphenols are found in plant-based foods (Appendix A Table A1) including fresh vegetables (e.g., broccoli, onion, cabbage, garlic, asparagus, carrots), fruits (grapes, pears, apples, cherries, and various berries), legumes (soybean), and cereals (whole grains). Other relevant dietary sources of polyphenols are identified in plant-derived beverages such as chocolate, coffee, tea, red wine, or extra-virgin olive oil [5,6]. There is now full awareness that foods that are rich in phytochemicals and polyphenols could play an important role in preserving human cardiovascular (CV) health [7], and substantial clinical evidence indicates that regular dietary consumption of such foods favorably affects carbohydrate metabolism [8]. This review briefly summarizes the evidence relating to dietary patterns rich in polyphenols with glucose metabolism and highlights the potential benefits of these compounds in the prevention of type 2 diabetes.

2. Dietary Pholyphenols and Diabetes Risk

High amounts of polyphenols are present in some diets such as the Mediterranean and the plant-based diet. The Mediterranean diet essentially refers to a dietary pattern rich in whole grains, fruits and vegetables, legumes, nuts, fish, olive oil, and with moderate wine consumption. It has been estimated that adherence to a Spanish Mediterranean diet led to a daily intake of polyphenols between 2590 and 3016 mg/die [9]. Plant-based diets involve eating plenty of vegetables, fruits, and cereals and a low amount of animal products; among plant-based diets, Pesco-Vegetarian, Semi-Vegetarian, and Lacto-ovo-Vegetarian diets contain the greatest amounts of polyphenols [10]. It is known that both the Mediterranean and plant-based diets are deemed “healthy diets” because, due to their content in polyphenols, they have been shown to improve carbohydrate metabolism and glucose tolerance [11]. Therefore, the potential benefit of these diets for prevention of type 2 diabetes has been tested in intervention studies. A prospective study that included 6798 participants from the Rotterdam Study demonstrated that high adherence to a plant-based versus animal-based diet was associated with a lower risk of insulin resistance, prediabetes, and diabetes, even after adjusting for confounders such as sociodemographic and lifestyle factors (food supplements, medications use, physical exercise) [12]. Similar findings were obtained from the pooled analysis of three big databases (Nurses’ Health Study, Nurses’ Health Study 2 and Health Professionals Follow-Up Study) [13] in which a healthful plant-based diet rich in whole grains, fruits, vegetables, nuts, legumes, vegetable oils, and tea/coffee was associated with substantially lower risk of developing type 2 diabetes during the follow-up. Furthermore, as demonstrated in a meta-analysis that included data from 307,099 patients [14], plant-based diets that are enriched with healthful plant-based foods are beneficial for the primary prevention of type 2 diabetes. On the other hand, at least five large prospective studies reported a substantially lower risk to develop type 2 diabetes in healthy or at-risk subjects who ate a Mediterranean diet [15]. To date, the relative contribution of single components of the Mediterranean or the plant-based diets to type 2 diabetes prevention is not clearly understood.

In this context, the role of specific dietary components including a group of polyphenols has been extensively studied in the last decade. A randomized controlled trial reported that a diet naturally rich in polyphenols improves glucose metabolism in individuals at high risk of diabetes [16]. A meta-analysis of six prospective cohorts that involved 284,806 participants suggested that an increase in the total dietary flavonoids intake by approximately 500 mg/day is associated with a significant decrease of the risk to develop type 2 diabetes [17] and, consistently, another meta-analysis of 18 prospective studies [18] showed that diets rich in polyphenols, particularly flavonoids, play a role in the prevention of type 2 diabetes. A large epidemiological study showed that anthocyanins-rich diets with substantial consumption of specific whole fruits, including blueberries, grapes, and apples, was significantly associated with a reduced risk of diabetes [19]. In a 3-month randomized, double-blind, placebo-controlled trial of subjects with prediabetes or new onset diabetes, purified anthocyanins moderately reduced glycated hemoglobin [20]. Another recent study has indicated the potential benefit of anthocyanin-rich mixed berry preparations on post-prandial glucose and insulin response [21] thereby suggesting an improved insulin sensitivity. Further evidence comes from a recent metanalysis of 37 randomized controlled trials that demonstrates that consumption of anthocyanins for more than 8 weeks in doses of more than 300 mg/day significantly decreases fasting and post-prandial glucose, glycated hemoglobin, and HOMA-index in overweight/obese individuals [22]. In addition, in a Korean study involving 4186 individuals, the consumption of flavonols and flavones was directly associated with insulin sensitivity among male subjects [23]. According to all these studies, it could be stated that current evidence indicates the benefits of polyphenols-enriched diets, particularly with flavonoids, on insulin sensitivity that could translate to a significantly reduced risk to develop type 2 diabetes. It is appropriate, however, to mention that other studies have not confirmed this evidence [24] and a prospective, cross-sectional analysis of 38,018 women reported did not observe any relationship between flavonols or flavones dietary intake and the risk of type 2 diabetes, and the intake of anthocyanidins was not linked to the risk of diabetes [25]. Inconsistencies among the results of these studies might be explained by substantial differences in the populations included the use of different types of polyphenols sources, adherence to dietary prescriptions with possible assessment of dietary intake, and the duration of exposure.

3. Specific Dietary Sources of Polyphenols and Diabetes Risk

3.1. Grains and Soy

Regular consumption of whole-grain products has been associated with a significant reduction in the risk of type 2 diabetes and lower CV mortality in many prospective studies [26,27,28]. Inverse associations between whole-grain intake, fasting insulin, and insulin sensitivity have been reported [29], although differences may occur due to grain variety. For instance, whole-wheat breads are associated with lower glycemic responses than white bread [30], and this has been attributed, at least in part, to the polyphenols content in the bran fraction of whole wheat [31]. It was demonstrated that ferulic acid contained in whole grains decreases cellular glucose uptake into epithelial cells in the small intestine and therefore might account for the attenuation of postprandial hyperglycemia by inhibition of glucose absorption [32]. Although dietary intake of soy protein and soy isoflavones was found to be inversely related to new onset type 2 diabetes in two meta-analyses of prospective studies [33,34], the evidence currently available on the possible benefits of soy on glucose metabolism is still preliminary and needs further investigation.

3.2. Fruits and Vegetables

Apples are rich in bioactive polyphenols and were found to decrease postprandial blood glucose in two small randomized controlled trials [35,36] conducted in healthy subjects. However, a recent study of subjects who consumed apples on a regular basis did not show any improvements of fasting blood glucose or serum insulin when compared to controls [37].

It is well known that berries are rich in polyphenols and contain a wide variety of phenolic molecules, ranging from phenolic acids (hydroxybenzoic and hydroxycinnamic acids), flavonoids (anthocyanins, flavonols, and flavan-3-ols) to polymerized compounds (proanthocyanins and ellagitannins) [38]. In a study conducted in prediabetic subjects with an oral glucose test, raspberry reduced the post-glucose load peak serum glucose and insulin levels and the area under the curve of glucose and insulin response [39]. In an elegant double-blind randomized controlled trial, consumption of 333 mg/day of polyphenols from strawberries and cranberries for 6 weeks improved insulin sensitivity and decreased compensatory insulin hypersecretion in patients with overweight [40]. Conversely, findings of other studies indicate that daily consumption of cranberry beverages for 8 weeks does not improve insulin sensitivity [41] and consumption of 140 g/day of blueberries with a carbohydrate breakfast meal does not affect glucose metabolism, nor the gastrointestinal hormones Glucagon Like Peptide 1 (GLP-1), Gastro Inhibitory Peptide, and peptide YY.

Also, pomegranate has an elevated content of bioactive polyphenols, and possible glucose-lowering effects of this fruit have been reported in animal studies [42], but intervention studies in humans have generated controversial results. In a randomized, cross-over, controlled study on healthy volunteers, beverages containing pomegranate polyphenols (mainly tannins) were found to reduce the postprandial glycemic response to a bread meal [43]. However, a meta-analysis of 16 randomized controlled trials showed that pomegranate intake did not have any favorable effect on glucose metabolism and insulin sensitivity [44].

Among additional promising antidiabetic compounds, citrus flavonoids were reported to modulate the intracellular pathways related to cell glucose uptake and insulin sensitivity and therefore they might have relevance in the prevention of diabetes, although this role needs to be verified in appropriately designed human studies [45].

Because of its abundant content of polyphenols, kiwifruit was sought to have beneficial metabolic effects, mostly relevant for carbohydrate metabolism. However, a meta-analysis of five randomized controlled trials has reported no favorable metabolic effect of kiwifruit in patients with cardiovascular risk factors [46].

Onion bulbs are one of the greater sources of dietary flavonoids and contribute significantly to the overall intake of flavonoids in common diets [47]. Preclinical studies suggested that onion bulbs and its active components may be considered as prophylactic or therapeutic agents against diabetes through a variety of mechanisms including an antioxidant, α-glucosidase, and α-amylase inhibitory effect, up-regulation of adiponectin receptors, reduction of insulin resistance and glucose intestinal absorption, elevation of hepatic and muscular glycogen content, increase of insulin secretion, and phosphorylation of AMP-activated protein kinase [48]. The metabolic effects of onion consumption were tested in a randomized controlled trial conducted in overweight/obese women with polycystic ovary syndrome reporting no significant difference in fasting blood sugar after 8 weeks [49]. In another randomized, placebo-controlled, 8-week trial, dietary raw yellow onion at the doses of 100 to 160 g/day improved doxorubicin-related insulin resistance and hyperglycemia in women with breast cancer [50].

Broccoli and broccoli sprouts are important sources of bioactive compounds including isothiocyanates, glycosylates, flavonoids, and phenols, all compounds that may improve insulin resistance. In a small randomized clinical trial, the consumption of 10 g/day of broccoli sprouts for 4 weeks resulted in a significant decrease in fasting serum insulin concentration and HOMA-index [51]. In another open trial, a combined meal of cooked broccoli and mashed potato had significantly lower serum glucose and insulin responses in comparison to potato eaten alone, suggesting that broccoli favorably affect glucose homeostasis [52].

In summary, polyphenols are contained in many fruits and vegetables whose effects could contribute significantly to an improvement of glucose metabolism and insulin sensitivity, possibly leading to the prevention of type 2 diabetes. However, the evidence obtained in intervention studies is still controversial for many types of fruits and vegetables and will need more extensive investigation before these dietary recommendations could be considered as mandatory in subjects at risk of developing type 2 diabetes.

3.3. Olive Oil

Extra-virgin olive oil is one of the components that most differentiates the Mediterranean diet from other dietary patterns. Phenolic compounds such as oleuropein and hydroxytyrosol, flavonoids, especially flavones, and lignans are abundant in extra-virgin olive oil [53]. The phenolic composition of olive oil ranges from 50 to 800 mg/L depending upon several factors including, among others, variety, cultivation techniques, degree of ripeness, and climate [54].

The effects of olive oil consumption on prevention of type 2 diabetes have been tested in many randomized clinical trials. The PREDIMED trial examined the effects on glucose metabolism of a Mediterranean diet with extra supplements of extra-virgin olive oil [55] and showed that this diet lowered the risk of type 2 diabetes by 40% in patients with high cardiovascular risk in comparison to a control group. Other analyses of the PREDIMED trial showed a significant reduction of new-onset type 2 diabetes in elderly individuals with the highest dietary intake of phenols and an inverse correlation between the degree of obesity and phenol consumption [56].

Recently, the PREDIABOLE study has tested the effect of increased intake of oleanolic acid on new-onset diabetes in prediabetic subjects [57]. In another randomized cross-over study of 30 patients with impaired fasting glucose, a meal containing 10 g of extra-virgin olive oil decreased blood glucose levels probably by inhibition of Dipeptidyl-peptidase-4 activity and increase of insulin and GLP-1 secretion [58]. The potential benefits of olive oil for the prevention of type 2 diabetes have been confirmed in a meta-analysis of 29 prospective studies in which the highest olive oil dietary intake category showed a 16% reduction in the risk of type 2 diabetes [59]. Thus, current evidence suggests that diets enriched with olive oil might prevent new-onset diabetes, an effect that, at least in part, could be attributed to the polyphenol content of oil.

3.4. Red Wine

A moderate and regular wine consumption is another typical component of the Mediterranean diet. Polyphenols are highly concentrated in red wine and come from the skin and seeds of grapes extracted during fermentation. The amount of polyphenols in a glass of red wine is approximately 200 mg compared with the 30 mg contained in a glass of white wine. Results of a small randomized controlled trial involving men at high cardiovascular risk support the hypothesis of a beneficial effect of the non-alcoholic fraction of red wine (mainly polyphenols) on insulin-resistanc; moreover, polyphenols of red wine were reported to be beneficial on and plasma lipids concentrations [60].

Resveratrol is a stilbenoid present in a variety of plants, such as Polygonum cuspidatum, grapes, and peanuts, and is considered one of main polyphenolic compounds of red wines. Experimental animal and human studies have shown that resveratrol has many beneficial metabolic effects due to its ability to improve insulin sensitivity and beta-cell function [61]. A meta-analysis of 30 studies that evaluated the effect of resveratrol on glucose, insulin, and glycated hemoglobin levels and insulin resistance (HOMA-index) reported a significant reduction of fasting glucose and insulin levels but no significant changes in glycated hemoglobin and HOMA-index.

In summary, there is currently limited evidence of the effect of red wine polyphenols on glucose metabolism and insulin sensitivity. More studies would be needed to better understand the antidiabetic properties of resveratrol, as well as to define the therapeutic potential of other stilbenes in the prevention of type 2 diabetes.

3.5. Tea, Coffee, and Chocolate

Encouraging data regarding the capacity of polyphenols to prevent type 2 diabetes were obtained in studies that investigated the effects of phenolic acids contained in tea and coffee in China and Japan [62,63]. In a randomized, controlled, cross-over study of obese subjects, a daily dose of flavonoid-rich black tea decreased postprandial glucose and insulin concentrations [64]. Green tea was superior to metformin in improving glycemic control in a randomized controlled trial conducted in 120 non-diabetic overweight women [65]. A meta-analysis of 17 randomized studies showed that green tea had favorable effects on glucose metabolism, decreasing fasting glucose and glycated hemoglobin concentrations [66]. Conversely, another meta-analysis of seven trials reported that consumption of green tea did not affect fasting plasma glucose and insulin levels, post-load plasma glucose, glycated hemoglobin, and HOMA-index in subjects at risk of new-onset type 2 diabetes [67].

A recent meta-analysis of 28 prospective studies on 1,109,272 non-diabetic subjects showed a 33% lower incidence of type 2 diabetes in habitual coffee drinkers (one to six cups of coffee/day, with and without caffeine) than in non-consumers [68]. However, in another study conducted in healthy subjects, coffee beverages with different contents of chlorogenic acids did not show any significant effect on glucose or insulin responses [69].

Cocoa flavanols are present in good amounts in dark chocolate, with a content of catechin and epicatechin (estimated to be approximately 20 times higher than in tea [70]) that was reported to have some beneficial effects on glucose metabolism. Furthermore, a meta-analysis of 42 randomized controlled trials with acute or chronic consumption of chocolate or cocoa reported an improvement in insulin sensitivity associated with a decrease in serum insulin [71]. Cocoa-related polyphenol intake may also result beneficial in reducing appetite and body weight although this effect needs further investigation [72].

4. Conclusions

In conclusion, although many epidemiological studies suggest that diets based on foods rich in polyphenols are associated with a significant reduction in the risk of developing type 2 diabetes, findings of studies on specific compounds are still controversial (Appendix A Table A2). This might be due to broad differences in the populations included in studies, the types of food, the assessment of dietary intake, and the duration of exposure. Furthermore, foods are a source of several types of polyphenols so the potential benefits on glucose metabolism are more likely to be mediated by the mixture and integration of them than the activity of a single compound. Thus, to date, it is not possible to draw definitive conclusions on the effects of specific polyphenols on glucose metabolism and on their possible role in prevention of type 2 diabetes. More evidence obtained in accurately designed dietary studies will be needed before polyphenol-rich foods could be includes as a mainstay of the dietary prescription in subjects at risk of type 2 diabetes.

Appendix A

Table A1.

Polyphenol content of foods and their effects on glucose metabolism. * data adapted from http://phenol-explorer.eu/cite_us database (accessed on 29 March 2021) ° data From J Pèrez-Jimenez et al. European Journal of Nutrition (2010) 64 S112 S120 [73].

Dietary Source Polyphenols Content (Class) * Main Content for Serving ° Supposed Benefic Effects on Glucose Metabolism
Wheat Whole Grain flour Flavones
Alkylphenols
Hydroxycinnamic acids
14 mg Reduction of fasting insulin and insulin resistance.
Soy flour Isoflavonoids 93 mg Inconsistent data
Apples Anthocyanins
Dihydrochalcones
Flavanols
Flavonols
Hydroxybenzoic acids
Hydroxycinnamic acids
149 mg Reduction of Postprandial Glucose
Blackberry Flavonols
Hydroxybenzoic acids
374 mg Reduction of insulin resistance.
Red Raspberry Anthocyanins
Flavanols
Flavonols
Hydroxybenzoic acids
Hydroxycinnamic acids
310 mg Lower glycemic peak, reduction of serum insulin, better insulin response.
Strawberry Anthocyanins
Flavanols
Flavonols
Hydroxybenzoic acids
Hydroxycinnamic acids
Stillbenes
390 mg Improved insulin sensitivity, decreased insulin hypersecretion.
Pomegranate Anthocyanins
Dihydrochakcones
Flavanols
Flavonols
Hydroxybenzoic acids
Hydroxycinnamic acids
1.1 mg Reduction of postprandial glucose.
Citrus Flavanones
Flavones
Flavonols
Lignans
42 mg Reduction of glucose uptake, improvement of insulin sensivity
Red Onion Anthocyanins
Flavonols
Hydroxybenzoic acids
50 mg Alfa-glucosidase ad alfa-amylase inhibition.
Upregulation of adiponectin receptors
Reduction of insulin resistance
Increase of insulin secretion
Activation of AMP-Activated protein kinase
Yellow Onion Flavonols
Hydroxybenzoic acids
22 mg
Broccoli Flavonols
Hydroxycinnamic acids
33 mg Reduction of insulin resistance
Red Wine Anthocyanins
Flavonols
Hydroxycinnamic acids
126 mg Reduction of insulin resistance
Improve beta-cell function
Olive Oil Flavones
Hydroxybenxoic acids
Hydroxycinnamic acids
Hydroxyphenylacetic acids
Lignans
Hydroxybenzaldehydes
Tyrosols
10 mg Reduction of insulin resistance
Dipeptidil-Dipeptidase-4 inhibition
Increase GLP1 secretion
Cocoa (dark chocolate) Flavanols
Flavonols
Hydroxycinnamic acids
Stillbenes
283 mg Reduction of insulin resistance
Reduction of appetite
Coffee Hydroxycinnamic acids
Alkylmethoxyphenols
Alkyphenols
Methoxyphenols
408 mg Reduction of insulin resistance
Black Tea Flavanols
Flavonols
Hydroxybenxoic acids
Hydroxycinnamic acids
197 mg Reduction of postprandial glucose.
Reduction of insulin resistance
Green Tea Flavanols
Flavonols
Hydroxybenxoic acids
Hydroxycinnamic acids
173 mg

Table A2.

Preclinical studies mentioned in the manuscript, study design, main objectives, and findings.

Design Main Objectives Main Findings
Shamloo M et al. [30] Experimental on cellular cultures. Effects of Phenolic acids extracted from whole grains on glucose uptake in human Caco-2E cells Glucose uptake inhibition was positively associated with the phenolic acids content.
Castro-Acosta ML et al. [35] Double blind, crossover trial in 25 healthy subjects and in vitro study of possible mechanism. Evaluate the effects of Apple and blackcurrant polyphenols rich drinks versus placebo on post-prandial glucose and incretin response to meal in humans. Apple Polyphenols reduce postprandial insulin, C-Peptide and insulin area under the curve at 30 min.
Prpa E J et al. [36] Double blind, crossover acute trial in 34 healthy subjects an in vitro study of possible mechanism. Evaluate the effect of Apple Extract (with different content of polyphenols and phlorizin) vs. placebo on post-prandial glucose.
Test the capacity of Apple Extract to inhibit cellular glucose transport
Polyphenol enriched apple extract reduced plasma glucose and insulin area under the curve at 30 min. In vitro model apple extract inhibits cellular glucose uptake in a dose dependent manner.
Xiao D. et al. [39] Controlled three arm single-blinded, crossover randomized clinical trial in 32 adults with obesity and insulin resistance. Evaluate the effect of red raspberry intake versus placebo on meal induced metabolic responses. Compared to placebo Red raspberry reduced insulin area under the curve, peak glucose, peak insulin ad 2 h glucose area under the curve.
Paquette M, et al. [40] Parallel double blind controlled and randomized trial in 41 overweight subjects Evaluate the effect of strawberry and cranberry polyphenols consumption on insulin sensitivity, glucose tolerance and insulin secretion using the euglycemic iperinsulinemic clamp technique. 6 weeks consumption of strawberry and cranberry extract was associated to significant improvement in insulin sensitivity and insulin secretion.
Hsia DS, et al. [41] Parallel double blind controlled and randomized trial in 35 overweight subjects Evaluate the effect of cranberry consumption on insulin sensitivity, glucose tolerance and insulin secretion using the euglycemic iperinsulinemic clamp technique. 8 weeks consumption of cranberry extract has no effects on insulin sensitivity and insulin secretion.
Kerimi A. et al. [42] double blind randomized, crossover, controlled trial in 16 healthy subjects Evaluate versus placebo the acute effect of pomegranate juice and polyphenol rich extract from pomegranate on the bread derived postprandial blood glucose concentration. Pomegranate polyphenols in beverage reduced post-prandial response to bread.
Ebrahimi-Mamaghani M et al. [49] randomized controlled trial in 53 overweight woman with polycystic ovarian syndrome Evaluate the effect of 8-week consumption of raw red onion consumption on metabolic features. No effects of fasting glucose, modest cholesterol lowering activity.
Jafarpour-Sadegh F et al. [50] parallel, triple blind controlled and randomized trial in 56 woman with breast cancer treated with doxorubicin. Evaluate the effect of 8-week consumption of fresh yellow onion consumption on glucose metabolism. Higher consumption of fresh yellow onion was associated with reduced fasting glucose and decreased insulin resistance.
Carnevale R et al. [58] randomized, crossover, controlled trial in 30 subjects with prediabetes Effects of 10 g extravirgin olive oil on post-prandial glucose and incretins Extravirgin olive oil improved postprandial glucose an was associated with reduced activity of dipeptidyl-peptidase 4 and increased postprandial concentration of Glucagon Like Peptide 1
Chiva-Blanch G. et al. [60] randomized, crossover, controlled trial in 67 subjects with high cardiovascular risk Effects of 4 week consumption of dealcoholized red wine on glucose metabolism. Consumption of dealcoholized red wine (with main content of polyphenols) reduced insulin resistance and fasting insulin.
Alves Ferreira M et al. [65] double blind randomized, crossover, controlled trial in 120 non diabetic overweight woman Evaluate effect of 12 week consumption of green tea versus 1 g metformin on glycemic control Green tea consumption had similar effects to metformin on glycemic control.

Author Contributions

Conceptualization, A.D.P. and L.A.S.; methodology, G.C.; investigation, A.D.P. and V.C.; resources A.C.; data curation, C.C.; writing—original draft preparation, A.D.P. and L.A.S.; writing—review and editing, A.D.P. and L.A.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.El Gharras H. Polyphenols: Food sources, properties and applications-A review. Int. J. Food Sci. Technol. 2009;44:2512–2518. doi: 10.1111/j.1365-2621.2009.02077.x. [DOI] [Google Scholar]
  • 2.Kabera J.N., Semana E., Mussa A.R., He X. Plant secondary metabolites: Biosynthesis, classification, function and pharmacological properties. J. Pharm. Pharmacol. 2014;2:377–392. [Google Scholar]
  • 3.Durazzo A., Lucarini M., Souto E.B., Cicala C., Caiazzo E., Izzo A.A., Novellino E., Santini A. Polyphenols: A concise overview on the chemistry, occurrence, and human health. Phytother. Res. 2019;33:2221–2243. doi: 10.1002/ptr.6419. [DOI] [PubMed] [Google Scholar]
  • 4.Khadem S., Marles R.J. Monocyclic Phenolic Acids; Hydroxy- and Polyhydroxybenzoic Acids: Occurrence and Recent Bioactivity Studies. Molecules. 2010;15:7985–8005. doi: 10.3390/molecules15117985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Pandey K.B., Rizvi S.I. Plant Polyphenols as Dietary Antioxidants in Human Health and Disease. Oxidative Med. Cell. Longev. 2009;2:270–278. doi: 10.4161/oxim.2.5.9498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Del Rio D., Rodriguez-Mateos A., Spencer J.P., Tognolini M., Borges G., Crozier A. Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases. Antiox. Redox Signal. 2013;18:1818–1892. doi: 10.1089/ars.2012.4581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Fraga C.G., Croft K.D., Kennedy D.O., Tomás-Barberán F.A. The effects of polyphenols and other bioactives on human health. Food Funct. 2019;10:514–528. doi: 10.1039/C8FO01997E. [DOI] [PubMed] [Google Scholar]
  • 8.Cao H., Ou J., Chen L., Zhang Y., Szkudelski T., Delmas D., Daglia M., Xiao J. Dietary polyphenols and type 2 diabetes: Human Study and Clinical Trial. Crit. Rev. Food Sci. Nutr. 2019;59:3371–3379. doi: 10.1080/10408398.2018.1492900. [DOI] [PubMed] [Google Scholar]
  • 9.Saura-Calixto F., Serrano J., Goñi I. Intake and bioaccessibility of total polyphenols in a whole diet. Food Chem. 2007;101:492–501. doi: 10.1016/j.foodchem.2006.02.006. [DOI] [Google Scholar]
  • 10.Burkholder-Cooley N., Rajaram S., Haddad E., Fraser G.E., Jaceldo-Siegl K. Comparison of polyphenol intakes according to distinct dietary patterns and food sources in the Adventist Health Study-2 cohort. Br. J. Nutr. 2016;115:2162–2169. doi: 10.1017/S0007114516001331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hanhineva K., Törrönen R., Bondia-Pons I., Pekkinen J., Kolehmainen M., Mykkänen H., Poutanen K. Impact of Dietary Polyphenols on Carbohydrate Metabolism. Int. J. Mol. Sci. 2010;11:1365–1402. doi: 10.3390/ijms11041365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chen Z., Zuurmond M.G., Van Der Schaft N., Nano J., Wijnhoven H.A.H., Ikram M.A., Franco O.H., Voortman T. Plant versus animal based diets and insulin resistance, prediabetes and type 2 diabetes: The Rotterdam Study. Eur. J. Epidemiol. 2018;33:883–893. doi: 10.1007/s10654-018-0414-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Satija A., Bhupathiraju S.N., Rimm E.B., Spiegelman D., Chiuve S.E., Borgi L., Willett W.C., Manson J.E., Sun Q., Hu F.B. Plant-Based Dietary Patterns and Incidence of Type 2 Diabetes in US Men and Women: Results from Three Prospective Cohort Studies. PLoS Med. 2016;13:e1002039. doi: 10.1371/journal.pmed.1002039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Qian F., Liu G., Hu F.B., Bhupathiraju S.N., Sun Q. Association Between Plant-Based Dietary Patterns and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis. JAMA Intern. Med. 2019;179:1335–1344. doi: 10.1001/jamainternmed.2019.2195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Esposito K., Giugliano D. Mediterranean diet and type 2 diabetes. Diabetes/Metabolism Res. Rev. 2014;30:34–40. doi: 10.1002/dmrr.2516. [DOI] [PubMed] [Google Scholar]
  • 16.Bozzetto L., Annuzzi G., Pacini G., Costabile G., Vetrani C., Vitale M., Griffo E., Giacco A., De Natale C., Cocozza S., et al. Polyphenol-rich diets improve glucose metabolism in people at high cardiometabolic risk: A controlled randomized intervention trial. Diabetologia. 2015;58:1551–1560. doi: 10.1007/s00125-015-3592-x. [DOI] [PubMed] [Google Scholar]
  • 17.Liu Y.-J., Zhan J., Liu X.-L., Wang Y., Ji J., He Q.-Q. Dietary flavonoids intake and risk of type 2 diabetes: A meta-analysis of prospective cohort studies. Clin. Nutr. 2014;33:59–63. doi: 10.1016/j.clnu.2013.03.011. [DOI] [PubMed] [Google Scholar]
  • 18.Rienks J., Barbaresko J., Oluwagbemigun K., Schmid M., Nöthlings U. Polyphenol exposure and risk of type 2 diabetes: Dose-response meta-analyses and systematic review of prospective cohort studies. Am. J. Clin. Nutr. 2018;108:49–61. doi: 10.1093/ajcn/nqy083. [DOI] [PubMed] [Google Scholar]
  • 19.Muraki I., Imamura F., Manson J.E., Hu F.B., Willett W.C., van Dam R.M., Sun Q. Fruit consumption and risk of type 2 diabetes: Results from three prospective longitudinal cohort studies. BMJ. 2013;347:f5001. doi: 10.1136/bmj.f5001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Yang L., Ling W., Yang Y., Chen Y., Tian Z., Du Z., Chen J., Xie Y., Liu Z., Yang L. Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes—A Randomized Controlled Trial. Nutrients. 2017;9:1104. doi: 10.3390/nu9101104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Solverson P.M., Henderson T.R., Debelo H., Ferruzzi M.G., Baer D.J., Novotny J.A. An Anthocyanin-Rich Mixed-Berry Intervention May Improve Insulin Sensitivity in a Randomized Trial of Overweight and Obese Adults. Nutrients. 2019;11:2876. doi: 10.3390/nu11122876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fallah A.A., Sarmast E., Jafari T. Effect of dietary anthocyanins on biomarkers of glycemic control and glucose metabolism: A systematic review and meta-analysis of randomized clinical trials. Food Res. Int. 2020;137:109379. doi: 10.1016/j.foodres.2020.109379. [DOI] [PubMed] [Google Scholar]
  • 23.Yeon J.-Y., Bae Y.J., Kim E.-Y., Lee E.-J. Association between flavonoid intake and diabetes risk among the Koreans. Clin. Chim. Acta. 2015;439:225–230. doi: 10.1016/j.cca.2014.10.042. [DOI] [PubMed] [Google Scholar]
  • 24.Giacco R., Costabile G., Fatati G., Frittitta L., Maiorino M.I., Marelli G., Parillo M., Pistis D., Tubili C., Vetrani C., et al. Effects of polyphenols on cardio-metabolic risk factors and risk of type 2 diabetes. A joint position statement of the Diabetes and Nutrition Study Group of the Italian Society of Diabetology (SID), the Italian Association of Dietetics and Clinical Nutrition (ADI) and the Italian Association of Medical Diabetologists (AMD) Nutr. Metab. Cardiovasc. Dis. 2020;30:355–367. doi: 10.1016/j.numecd.2019.11.015. [DOI] [PubMed] [Google Scholar]
  • 25.Song Y., Manson J.E., Buring J.E., Sesso H.D., Liu S. Associations of Dietary Flavonoids with Risk of Type 2 Diabetes, and Markers of Insulin Resistance and Systemic Inflammation in Women: A Prospective Study and Cross-Sectional Analysis. J. Am. Coll. Nutr. 2005;24:376–384. doi: 10.1080/07315724.2005.10719488. [DOI] [PubMed] [Google Scholar]
  • 26.Gil A., Ortega R.M., Maldonado J. Wholegrain cereals and bread: A duet of the Mediterranean diet for the prevention of chronic diseases. Public Health Nutr. 2011;14:2316–2322. doi: 10.1017/S1368980011002576. [DOI] [PubMed] [Google Scholar]
  • 27.Wu H., Flint A.J., Qi Q., van Dam R.M., Sampson L.A., Rimm E.B., Holmes M.D., Willett W.C., Hu F.B., Sun Q. Association between dietary whole grain intake and risk of mortality: Two large prospective studies in US men and women. JAMA Inter. Med. 2015;175:373–384. doi: 10.1001/jamainternmed.2014.6283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Aune D., Norat T., Romundstad P., Vatten L.J. Whole grain and refined grain consumption and the risk of type 2 diabetes: A systematic review and dose–response meta-analysis of cohort studies. Eur. J. Epidemiol. 2013;28:845–858. doi: 10.1007/s10654-013-9852-5. [DOI] [PubMed] [Google Scholar]
  • 29.McKeown N.M., Meigs J.B., Liu S., Wilson P.W.F., Jacques P.F. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am. J. Clin. Nutr. 2002;76:390–398. doi: 10.1093/ajcn/76.2.390. [DOI] [PubMed] [Google Scholar]
  • 30.Ludwig D.S., Eckel R.H. The glycemic index at 20y. Am. J. Clin. Nutr. 2002;76:264S–265S. doi: 10.1093/ajcn/76.1.264S. [DOI] [PubMed] [Google Scholar]
  • 31.Scalbert A., Williamson G. Dietary Intake and Bioavailability of Polyphenols. J. Nutr. 2000;130:2073S–2085S. doi: 10.1093/jn/130.8.2073S. [DOI] [PubMed] [Google Scholar]
  • 32.Shamloo M., Jones P.J.H., Eck P.K. Inhibition of Intestinal Cellular Glucose Uptake by Phenolics Extracted from Whole Wheat Grown at Different Locations. J. Nutr. Metab. 2018;2018:5421714. doi: 10.1155/2018/5421714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Tang J., Wan Y., Zhao M., Zhong H., Zheng J.-S., Feng F. Legume and soy intake and risk of type 2 diabetes: A systematic review and meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 2020;111:677–688. doi: 10.1093/ajcn/nqz338. [DOI] [PubMed] [Google Scholar]
  • 34.Li W., Ruan W., Peng Y., Wang D. Soy and the risk of type 2 diabetes mellitus: A systematic review and meta-analysis of observational studies. Diabetes Res. Clin. Pract. 2018;137:190–199. doi: 10.1016/j.diabres.2018.01.010. [DOI] [PubMed] [Google Scholar]
  • 35.Castro-Acosta M.L., Stone S.G., Mok J.E., Mhajan R.K., Fu C.-I., Lenihan-Geels G.N., Corpe C.P., Hall W.L. Apple and blackcurrant polyphenol-rich drinks decrease postprandial glucose, insulin and incretin response to a high-carbohydrate meal in healthy men and women. J. Nutr. Biochem. 2017;49:53–62. doi: 10.1016/j.jnutbio.2017.07.013. [DOI] [PubMed] [Google Scholar]
  • 36.Prpa E.J., Corpe C.P., Atkinson B., Blackstone B., Leftley E.S., Parekh P., Philo M., Kroon P.A., Hall W.L. Apple polyphenol-rich drinks dose-dependently decrease early-phase postprandial glucose concentrations following a high-carbohydrate meal: A randomized controlled trial in healthy adults and in vitro studies. J. Nutr. Biochem. 2020;85:108466. doi: 10.1016/j.jnutbio.2020.108466. [DOI] [PubMed] [Google Scholar]
  • 37.Koutsos A., Riccadonna S., Ulaszewska M.M., Franceschi P., Trošt K., Galvin A., Braune T., Fava F., Perenzoni D., Mattivi F., et al. Two apples a day lower serum cholesterol and improve cardiometabolic biomarkers in mildly hypercholesterolemic adults: A randomized, controlled, crossover trial. Am. J. Clin. Nutr. 2020;111:307–318. doi: 10.1093/ajcn/nqz282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Szajdek A., Borowska E.J. Bioactive compounds and health-promoting properties of berry fruits: A review. Plant Foods Hum. Nutr. 2008;63:147–156. doi: 10.1007/s11130-008-0097-5. [DOI] [PubMed] [Google Scholar]
  • 39.Xiao D., Zhu L., Edirisinghe I., Fareed J., Brailovsky Y., Burton-Freeman B. Attenuation of Postmeal Metabolic Indices with Red Raspberries in Individuals at Risk for Diabetes: A Randomized Controlled Trial. Obesity. 2019;27:542–550. doi: 10.1002/oby.22406. [DOI] [PubMed] [Google Scholar]
  • 40.Paquette M., Larqué A.S.M., Weisnagel S.J., Desjardins Y., Marois J., Pilon G., Dudonné S., Marette A., Jacques H. Strawberry and cranberry polyphenols improve insulin sensitivity in insulin-resistant, non-diabetic adults: A parallel, double-blind, controlled and randomised clinical trial. Br. J. Nutr. 2017;117:519–531. doi: 10.1017/S0007114517000393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Hsia D.S., Zhang D.J., Beyl R.S., Greenway F.L., Khoo C. Effect of daily consumption of cranberry beverage on insulin sensitivity and modification of cardiovascular risk factors in adults with obesity: A pilot, randomised, placebo-controlled study. Br. J. Nutr. 2020;124:577–585. doi: 10.1017/S0007114520001336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Katz S.R., Newman R.A., Lansky E.P. Punica granatum: Heuristic treatment for diabetes mellitus. J. Med. Food. 2007;10:213–217. doi: 10.1089/jmf.2006.290. [DOI] [PubMed] [Google Scholar]
  • 43.Kerimi A., Nyambe-Silavwe H., Gauer J.S., A Tomás-Barberán F., Williamson G. Pomegranate juice, but not an extract, confers a lower glycemic response on a high–glycemic index food: Randomized, crossover, controlled trials in healthy subjects. Am. J. Clin. Nutr. 2017;106:1384–1393. doi: 10.3945/ajcn.117.161968. [DOI] [PubMed] [Google Scholar]
  • 44.Huang H., Liao D., Chen G., Chen H., Zhu Y. Lack of efficacy of pomegranate supplementation for glucose management, insulin levels and sensitivity: Evidence from a systematic review and meta-analysis. Nutr. J. 2017;16:67. doi: 10.1186/s12937-017-0290-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Gandhi G.R., Vasconcelos A.B.S., Wu D.T., Li H.B., Antony P.J., Li H., Geng F., Gurgel R.Q., Narain N., Gan R.Y. Citrus flavonoids as promising phytochemicals targeting diabetes and related complications: A systematic review of in vitro and in vivo studies. Nutrients. 2020;12:2097. doi: 10.3390/nu12102907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Suksomboon N., Poolsup N., Lin W. Effect of kiwifruit on metabolic health in patients with cardiovascular risk factors: A systematic review and meta-analysis. Diabetes Metab. Syndr. Obes. 2019;12:171–180. doi: 10.2147/DMSO.S193225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Slimestad R., Fossen T., Vågen I.M. Onions: A Source of Unique Dietary Flavonoids. J. Agric. Food Chem. 2007;55:10067–10080. doi: 10.1021/jf0712503. [DOI] [PubMed] [Google Scholar]
  • 48.Galavi A., Hosseinzadeh H., Razavi B.M. The effects of Allium cepa L. (onion) and its active constituents on metabolic syndrome: A review. Iran. J. Basic Med. Sci. 2018;24:3–16. doi: 10.22038/ijbms.2020.46956.10843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ebrahimi-Mamaghani M., Saghafi-Asl M., Pirouzpanah S., Asghari-Jafarabadi M. Effects of raw red onion consumption on metabolic features in overweight or obese women with polycystic ovary syndrome: A randomized controlled clinical trial. J. Obstet. Gynaecol. Res. 2014;40:1067–1076. doi: 10.1111/jog.12311. [DOI] [PubMed] [Google Scholar]
  • 50.Jafarpour-Sadegh F., Montazeri V., Adili A., Esfehani A., Rashidi M.-R., Pirouzpanah S. Consumption of Fresh Yellow Onion Ameliorates Hyperglycemia and Insulin Resistance in Breast Cancer Patients During Doxorubicin-Based Chemotherapy: A Randomized Controlled Clinical Trial. Integr. Cancer Ther. 2017;16:276–289. doi: 10.1177/1534735416656915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Bahadoran Z., Tohidi M., Nazeri P., Mehran M., Azizi F., Mirmiran P. Effect of broccoli sprouts on insulin resistance in type 2 diabetic patients: A randomized double-blind clinical trial. Int. J. Food Sci. Nutr. 2012;63:767–771. doi: 10.3109/09637486.2012.665043. [DOI] [PubMed] [Google Scholar]
  • 52.Ballance S., Knutsen S.H., Fosvold Øivind W., Wickham M., Trenado C.D.-T., Monro J. Glyceamic and insulinaemic response to mashed potato alone, or with broccoli, broccoli fibre or cellulose in healthy adults. Eur. J. Nutr. 2016;57:199–207. doi: 10.1007/s00394-016-1309-7. [DOI] [PubMed] [Google Scholar]
  • 53.Ros E. Olive oil and CVD: Accruing evidence of a protective effect. Br. J. Nutr. 2012;108:1931–1933. doi: 10.1017/S0007114512003844. [DOI] [PubMed] [Google Scholar]
  • 54.Martín-Peláez S., Covas M.I., Fitó M., Kušar A., Pravst I. Health effects of olive oil polyphenols: Recent advances and possibilities for the use of health claims. Mol. Nutr. Food Res. 2013;57:760–771. doi: 10.1002/mnfr.201200421. [DOI] [PubMed] [Google Scholar]
  • 55.Estruch R., Ros E., Salas-Salvadó J., Covas M.-I., Corella D., Arós F., Gómez-Gracia E., Ruiz-Gutiérrez V., Fiol M., Lapetra J., et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N. Engl. J. Med. 2018;378:e34. doi: 10.1056/NEJMoa1800389. [DOI] [PubMed] [Google Scholar]
  • 56.Ditano-Vázquez P., Torres-Peña J.D., Galeano-Valle F., Pérez-Caballero A.I., Demelo-Rodríguez P., Lopez-Miranda J., Katsiki N., Delgado-Lista J., Alvarez-Sala-Walther L.A. The Fluid Aspect of the Mediterranean Diet in the Prevention and Management of Cardiovascular Disease and Diabetes: The Role of Polyphenol Content in Moderate Consumption of Wine and Olive Oil. Nutrients. 2019;11:2833. doi: 10.3390/nu11112833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Santos-Lozano J.M., Rada M., Lapetra J., Guinda Á., Jiménez-Rodríguez M.C., Cayuela J.A., Ángel-Lugo A., Vilches-Arenas Á., Gómez-Martín A.M., Ortega-Calvo M., et al. Prevention of type 2 diabetes in prediabetic patients by using functional olive oil enriched in oleanolic acid: The PREDIABOLE study, a randomized controlled trial. Diabetes Obes. Metab. 2019;21:2526–2534. doi: 10.1111/dom.13838. [DOI] [PubMed] [Google Scholar]
  • 58.Carnevale R., Loffredo L., Del Ben M., Angelico F., Nocella C., Petruccioli A., Bartimoccia S., Monticolo R., Cava E., Violi F. Extra virgin olive oil improves post-prandial glycemic and lipid profile in patients with impaired fasting glucose. Clin. Nutr. 2017;36:782–787. doi: 10.1016/j.clnu.2016.05.016. [DOI] [PubMed] [Google Scholar]
  • 59.Schwingshackl L., Lampousi A.-M., Portillo M.P., Romaguera D., Hoffmann G., Boeing H. Olive oil in the prevention and management of type 2 diabetes mellitus: A systematic review and meta-analysis of cohort studies and intervention trials. Nutr. Diabetes. 2017;7:e262. doi: 10.1038/nutd.2017.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Chiva-Blanch G., Urpi-Sarda M., Ros E., Valderas-Martinez P., Casas R., Arranz S., Guillén M., Lamuela-Raventós R.M., Llorach R., Andres-Lacueva C., et al. Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: A randomized clinical trial. Clin. Nutr. 2013;32:200–206. doi: 10.1016/j.clnu.2012.08.022. [DOI] [PubMed] [Google Scholar]
  • 61.Gong L., Guo S., Zou Z. Resveratrol ameliorates metabolic disorders and insulin resistance in high-fat diet-fed mice. Life Sci. 2020;242:117212. doi: 10.1016/j.lfs.2019.117212. [DOI] [PubMed] [Google Scholar]
  • 62.Jiang X., Zhang D., Jiang W. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: A meta-analysis of prospective studies. Eur. J. Nutr. 2013;53:25–38. doi: 10.1007/s00394-013-0603-x. [DOI] [PubMed] [Google Scholar]
  • 63.Iso H., Date C., Wakai K., Fukui M., Tamakoshi A., The JACC Study Group The Relationship between Green Tea and Total Caffeine Intake and Risk for Self-Reported Type 2 Diabetes among Japanese Adults. Ann. Intern. Med. 2006;144:554–562. doi: 10.7326/0003-4819-144-8-200604180-00005. [DOI] [PubMed] [Google Scholar]
  • 64.Fuchs D., Nyakayiru J., Draijer R., Mulder T.P.J., Hopman M.T.E., Eijsvogels T.M.H., Thijssen D.H. Impact of flavonoid-rich black tea and beetroot juice on postprandial peripheral vascular resistance and glucose homeostasis in obese, insulin-resistant men: A randomized controlled trial. Nutr. Metab. 2016;13:34. doi: 10.1186/s12986-016-0094-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Ferreira M.A., Gomes A.P.O., de Moraes A.P.G., Stringhini M.L.F., Mota J.F., Coelho A.S.G., Botelho P.B. Green tea extract outperforms metformin in lipid profile and glycaemic control in overweight women: A double-blind, placebo-controlled, randomized trial. Clin. Nutr. ESPEN. 2017;22:1–6. doi: 10.1016/j.clnesp.2017.08.008. [DOI] [PubMed] [Google Scholar]
  • 66.Liu K., Zhou R., Wang B., Chen K., Shi L.-Y., Zhu J.-D., Mi M.-T. Effect of green tea on glucose control and insulin sensitivity: A meta-analysis of 17 randomized controlled trials. Am. J. Clin. Nutr. 2013;98:340–348. doi: 10.3945/ajcn.112.052746. [DOI] [PubMed] [Google Scholar]
  • 67.Wang X., Tian J., Jiang J., Li L., Ying X., Tian H., Nie M. Effects of green tea or green tea extract on insulin sensitivity and glycaemic control in populations at risk of type 2 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials. J. Hum. Nutr. Diet. 2013;27:501–512. doi: 10.1111/jhn.12181. [DOI] [PubMed] [Google Scholar]
  • 68.Ding M., Bhupathiraju S.N., Chen M., Van Dam R.M., Hu F.B. Caffeinated and Decaffeinated Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review and a Dose-Response Meta-analysis. Diabetes Care. 2014;37:569–586. doi: 10.2337/dc13-1203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Rakvaag E., Dragsted L.O. Acute effects of light and dark roasted coffee on glucose tolerance: A randomized, controlled crossover trial in healthy volunteers. Eur. J. Nutr. 2015;55:2221–2230. doi: 10.1007/s00394-015-1032-9. [DOI] [PubMed] [Google Scholar]
  • 70.Miller K.B., Hurst W.J., Payne M.J., Stuart D.A., Apgar J., Sweigart D.S., Ou B. Impact of Alkalization on the Antioxidant and Flavanol Content of Commercial Cocoa Powders. J. Agric. Food Chem. 2008;56:8527–8533. doi: 10.1021/jf801670p. [DOI] [PubMed] [Google Scholar]
  • 71.Hooper L., Kay C., Abdelhamid A., A Kroon P., Cohn J.S., Rimm E.B., Cassidy A. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: A systematic review and meta-analysis of randomized trials. Am. J. Clin. Nutr. 2012;95:740–751. doi: 10.3945/ajcn.111.023457. [DOI] [PubMed] [Google Scholar]
  • 72.Halib H., Ismail A., Yusof B.-N.M., Osakabe N., Daud Z.A.M. Effects of Cocoa Polyphenols and Dark Chocolate on Obese Adults: A Scoping Review. Nutrients. 2020;12:3695. doi: 10.3390/nu12123695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Perezjimenez J., Neveu V., Vos F., Scalbert A. Identification of the 100 richest dietary sources of polyphenols: An application of the Phenol-Explorer database. Eur. J. Clin. Nutr. 2010;64(Suppl. S3):S112–S120. doi: 10.1038/ejcn.2010.221. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Not applicable.


Articles from Nutrients are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES